Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -3.77% | +4.55% | +14.43% |
04-15 | Top Premarket Decliners | MT |
01-30 | Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Sales 2022 | 40.14M 3.21B | Sales 2023 | 32.31M 2.58B | Capitalization | 3.46M 277M |
---|---|---|---|---|---|
Net income 2022 | -8M -640M | Net income 2023 | -6M -480M | EV / Sales 2022 | -0.07 x |
Net cash position 2022 | 14.92M 1.19B | Net cash position 2023 | 13.02M 1.04B | EV / Sales 2023 | -0.3 x |
P/E ratio 2022 |
-1.41
x | P/E ratio 2023 |
-0.56
x | Employees | 225 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 42.95% |
1 day | -3.77% | ||
1 week | +4.55% | ||
Current month | +5.02% | ||
1 month | +5.02% | ||
3 months | +12.75% | ||
6 months | +116.98% | ||
Current year | +14.43% |
Managers | Title | Age | Since |
---|---|---|---|
Gang Lai
CEO | Chief Executive Officer | 56 | - |
Lin Yang
DFI | Director of Finance/CFO | 48 | - |
Baochang Liu
COO | Chief Operating Officer | 44 | 30/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gang Lai
CEO | Chief Executive Officer | 56 | - |
Lin Yang
DFI | Director of Finance/CFO | 48 | - |
Jiawen Pang
BRD | Director/Board Member | 57 | 28/02/21 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 2.3 | -3.77% | 95 821 |
29/04/24 | 2.39 | +9.63% | 52,850 |
26/04/24 | 2.18 | -5.63% | 20,020 |
25/04/24 | 2.31 | +7.74% | 147,492 |
24/04/24 | 2.144 | -2.54% | 35,261 |
Delayed Quote Nasdaq, April 30, 2024 at 06:31 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+14.43% | 8.66M | |
+39.33% | 6.01B | |
-18.38% | 4.4B | |
-9.17% | 3.17B | |
+3.98% | 3.07B | |
-3.41% | 2.51B | |
+48.74% | 1.88B | |
-4.82% | 1.73B | |
-1.24% | 1.65B | |
-8.96% | 1.58B |
- Stock Market
- Equities
- UPC Stock